Umbilical cord–derived mesenchymal stromal cells in cardiovascular disease: review of preclinical and clinical data-Reference-Cited by-同舟云学术

Umbilical cord–derived mesenchymal stromal cells in cardiovascular disease: review of preclinical and clinical data

Published:2019-10 Issue:10 Volume:21 Page:1007-1018
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Colicchia Martina,Jones Daniel A.,Beirne Anne-Marie,Hussain Mohsin^ORCID,Weeraman Deshan^ORCID,Rathod Krishnaraj,Veerapen Jessry,Lowdell Mark,Mathur Anthony

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference101 articles.

1. The annual global economic burden of heart failure;Cook;Int J Cardiol,2014

2. Heart failure;Metra;Lancet,2017

3. The global health and economic burden of hospitalizations for heart failure;Ambrosy;J Am Coll Cardiol,2014

4. Clinical observation of umbilical cord mesenchymal stem cell treatment of severe systolic heart failure;Zhao;Genet Mol Res,2015

5. Stem cells in the treatment of cardiovascular disease—an overview;Hotkar;Stem Cell Rev Reports,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A prospective randomized controlled study of multi-intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure and reduced ejection fraction (PRIME-HFrEF) trial: Rationale and design;Contemporary Clinical Trials Communications;2024-10

2. Stem cell and exosome therapies for regenerating damaged myocardium in heart failure;Life Sciences;2024-08

3. QSAR Based Drug Repurposing: A New Paradigm in Breast Cancer Research;Indian Journal of Pharmaceutical Education and Research;2024-06-21

4. Efficacy and Mechanism of Highly Active Umbilical Cord Mesenchymal Stem Cells in the Treatment of Osteoporosis in Rats;Current Stem Cell Research & Therapy;2024-02-14

5. Therapeutic and regenerative potential of different sources of mesenchymal stem cells for cardiovascular diseases;BIOCELL;2024